SCHEMBL24700121

SCHEMBL24700121

CC(C)CCCC(=O)NCCOCCC(=O)C(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.45
LMNA P02545 2/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CNR1 P21554 2/20 0.39
CNR2 P34972 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GLP1R P43220 8/20 0.35
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26167786 0.94 HPGD (0.43) HPGDLMNAPKMTSHRMEN1
SCHEMBL24253180 0.92 TSHR (0.43) HPGDLMNAPKMTSHRMEN1
SCHEMBL17123136 0.91 ALDH1A1 (0.44) HPGDLMNAPKMTSHRMEN1
SCHEMBL27312098 0.89 MEN1 (0.45) HPGDLMNAPKMTSHRMEN1
SCHEMBL25128191 0.89 MEN1 (0.45) HPGDLMNAPKMTSHRMEN1
SCHEMBL27312182 0.89 MEN1 (0.45) HPGDLMNAPKMTSHRMEN1
SCHEMBL27312181 0.89 MEN1 (0.45) HPGDLMNAPKMTSHRMEN1
SCHEMBL26866027 0.88 GLP1R (0.41) HPGDLMNAPKMTSHRMEN1
SCHEMBL18707765 0.87 HPGD (0.49) HPGDLMNAPKMTSHRMEN1
SCHEMBL26412077 0.87 MEN1 (0.47) HPGDTSHRMEN1KMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158169-A1 LINKERS FOR IMPROVING THE STABILITY OF BIOCONJUGATES AND THE SELECTIVITY OF PAYLOAD RELEASE AUDAX PRIVATE DEBT LLC, AS AGENT 2023-05-25 US disclosed
US-11510994-B2 Linkers for improving the stability of bioconjugates and the selectivity of payload release EqIP, LLC (US) 2022-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11510994-B2 Linkers for improving the stability of bioconjugates and the selectivity of payload release CTSA, CTSS, CTSV HPGD 4459/4885LMNA 659/4885PKM 4052/4885
US-20230158169-A1 LINKERS FOR IMPROVING THE STABILITY OF BIOCONJUGATES AND THE SELECTIVITY OF PAYLOAD RELEASE CTSA, CTSS, CTSV HPGD 4459/4885LMNA 659/4885PKM 4052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.